In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes
- 15 July 1997
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 42 (2) , 147-150
- https://doi.org/10.1016/s0006-3223(97)00242-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Functional Imaging Patterns in Alzheimer's Disease Relationships to NeurobiologyaAnnals of the New York Academy of Sciences, 1996
- BrainN-acetyl-l-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy studyBrain Research, 1994
- Abnormal cerebral metabolite concentrations in patients with probable alzheimer diseaseMagnetic Resonance in Medicine, 1994
- Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imagingAnnals of Neurology, 1994
- Rapidly progressing atrophy of medial temporal lobe in Alzheimer's diseaseThe Lancet, 1994
- Temporal Lobe Regions on Magnetic Resonance Imaging Identify Patients With Early Alzheimer's DiseaseArchives of Neurology, 1993
- Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomographyThe Lancet, 1992
- N ‐acetyl‐L‐aspartate and other amino acid metabolites in Alzheimer's disease brainNeurology, 1992
- N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC MethodJournal of Neurochemistry, 1984
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984